Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Introduction

Inflammatory bowel disease (IBD) is a complex disorder that affects several populations around the world. The conventional treatments of IBD are associated with a heap of undesirable side effects. Therefore, the development of new treatment agents, particularly from natural sources, is urgent to reduce the widespread of this disease.

Objective

We aimed to investigate the intestinal anti-inflammatory effect of the ethanolic extract from (EFC) against colitis induced in mice.

Methods

Once the safety of EFC has been established through the evaluation of acute toxicity , we conducted an experiment on the BALB/c mouse model of colitis induced by DNBS to evaluate the potential anti-inflammatory effect of three doses of EFC (50, 100 and 200 mg/kg). In addition, we evaluated the antioxidant activity of the ethanolic extract using the Folin-Ciocalteu and the DPPH radical scavenging methods.

Results and Discussion

It was determined that the EFC extract has a high content of polyphenolic components along with potent antioxidant properties against the DPPH radical. Furthermore, EFC significantly reduced the degree of histological lesions and restored the mice's colons to their normal weight and length. Additionally, the pro-inflammatory and prooxidant (MPO) marker was considerably decreased by EFC. On the other hand, EFC increased the antioxidant marker Catalase activity.

Conclusion

These results suggest that the ethanolic extract of exerts potent antioxidant and anti-inflammatory activities and may serve as a candidate for more research and development of effective and natural therapeutic agents against inflammatory bowel disease.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072378267250514104332
2025-05-23
2026-03-10

  • From This Site

    /content/journals/cbc/10.2174/0115734072378267250514104332
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MulderD.J. NobleA.J. JustinichC.J. DuffinJ.M. A tale of two diseases: The history of inflammatory bowel disease.J. Crohn’s Colitis20148534134810.1016/j.crohns.2013.09.009 24094598
     [Google Scholar]
  2. ScaldaferriF. FiocchiC. Inflammatory bowel disease: Progress and current concepts of etiopathogenesis.J. Dig. Dis.20078417117810.1111/j.1751‑2980.2007.00310.x 17970872
     [Google Scholar]
  3. MolodeckyN.A. SoonI.S. RabiD.M. GhaliW.A. FerrisM. ChernoffG. BenchimolE.I. PanaccioneR. GhoshS. BarkemaH.W. KaplanG.G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.Gastroenterology201214214654.e4210.1053/j.gastro.2011.10.001 22001864
     [Google Scholar]
  4. PedersenN. DuricovaD. ElkjaerM. GamborgM. MunkholmP. JessT. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.Offi. J. Amer. Coll. Gastroenterol.201010571480148710.1038/ajg.2009.760 20332773
     [Google Scholar]
  5. BiasiF. LeonarduzziG. OteizaP.I. PoliG. Inflammatory bowel disease: Mechanisms, redox considerations, and therapeutic targets.Antioxid. Redox Signal.201319141711174710.1089/ars.2012.4530 23305298
     [Google Scholar]
  6. Piechota-PolanczykA. FichnaJ. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.Naunyn Schmiedebergs Arch. Pharmacol.2014387760562010.1007/s00210‑014‑0985‑1 24798211
     [Google Scholar]
  7. Sanchez-MuñozF. Dominguez-LopezA. Yamamoto-FurushoJ.K. Role of cytokines in inflammatory bowel disease.World J. Gastroenterol.200814274280428810.3748/wjg.14.4280 18666314
     [Google Scholar]
  8. GecseK.B. VermeireS. Differential diagnosis of inflammatory bowel disease: Imitations and complications.Lancet Gastroenterol. Hepatol.20183964465310.1016/S2468‑1253(18)30159‑6 30102183
     [Google Scholar]
  9. MosliM. Al BeshirM. Al-JudaibiB. Al-AmeelT. SaleemA. BessissowT. GhoshS. AlmadiM. Advances in the diagnosis and management of inflammatory bowel disease: Challenges and uncertainties.Saudi J. Gastroenterol.20142028110110.4103/1319‑3767.129473 24705146
     [Google Scholar]
  10. MowatC. ColeA. WindsorA. AhmadT. ArnottI. DriscollR. MittonS. OrchardT. RutterM. YoungeL. LeesC. HoG. SatsangiJ. BloomS. Guidelines for the management of inflammatory bowel disease in adults.Gut201160557160710.1136/gut.2010.224154 21464096
     [Google Scholar]
  11. CaiZ. WangS. LiJ. Treatment of inflammatory bowel disease: a comprehensive review.Front. Med. (Lausanne)2021876547410.3389/fmed.2021.765474 34988090
     [Google Scholar]
  12. BeaugerieL. RahierJ.F. KirchgesnerJ. Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases.Clin. Gastroenterol. Hepatol.20201861324133510.1016/j.cgh.2020.02.009 32059920
     [Google Scholar]
  13. BribiN. BelmouhoubM. MaizaF. Anti-inflammatory and analgesic activities of ethanolic extract of Fumaria capreolata.Phytotherapie201715421121610.1007/s10298‑016‑1035‑6
     [Google Scholar]
  14. BribiN. Rodríguez-NogalesA. VezzaT. AlgieriF. Rodriguez-CabezasM.E. Garrido-MesaJ. GálvezJ. Intestinal anti-inflammatory activity of the total alkaloid fraction from Fumaria capreolata in the DSS model of colitis in mice.Bioorg. Med. Chem. Lett.2020301812741410.1016/j.bmcl.2020.127414 32717615
     [Google Scholar]
  15. RasoanaivoP. WrightC.W. WillcoxM.L. GilbertB. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions.Malar. J.201110S1Suppl. 1S410.1186/1475‑2875‑10‑S1‑S4 21411015
     [Google Scholar]
  16. OrhanI.E. ŞenerB. MusharrafS.G. Antioxidant and hepatoprotective activity appraisal of four selected Fumaria species and their total phenol and flavonoid quantities.Exp. Toxicol. Pathol.201264320520910.1016/j.etp.2010.08.007 20829009
     [Google Scholar]
  17. PazJ.E.W. ContrerasC.R. MunguíaA.R. AguilarC.N. InungarayM.L.C. Phenolic content and antibacterial activity of extracts of Hamelia patens obtained by different extraction methods.Braz. J. Microbiol.201849365666110.1016/j.bjm.2017.03.018 29246664
     [Google Scholar]
  18. MerakebM.S. BribiN. FerhatR. YanatB. Inhibitory effects of linum usitatissimum alkaloid on inflammatory and nociceptive responses in mice.Curr. Bioact. Compd.20231925662
     [Google Scholar]
  19. MartelliL. RagazziE. Di MarioF. MartelliM. CastagliuoloI. Dal MaschioM. PalùG. MaschiettoM. ScorzetoM. VassanelliS. BrunP. A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid‐induced colitis in mice.Neurogastroenterol. Motil.200719866867410.1111/j.1365‑2982.2007.00928.x 17640182
     [Google Scholar]
  20. AziezM. BribiN. MerakebM.S. FerhatR. AffenaiS. Intestinal anti-inflammatory and antioxidant potential of Arthrospira platensis aqueous extract on DNBS-induced colitis in BALB/c mice.Curr. Chem. Biol.202418423824810.2174/0122127968320045240927120032
     [Google Scholar]
  21. AlexP. ZachosN.C. NguyenT. GonzalesL. ChenT.E. ConklinL.S. CentolaM. LiX. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.Inflamm. Bowel Dis.200915334135210.1002/ibd.20753 18942757
     [Google Scholar]
  22. MerakebM.S. BribiN. FerhatR. AziezM. YanatB. Alkaloids extract from Linum usitatissimum attenuates 12-OTetradecanoylphorbol-13-Acetate (TPA)-induced inflammation and oxidative stress in mouse skin.Antiinflamm. Antiallergy Agents Med. Chem.202121317918710.2174/1871523022666221212121621 36515033
     [Google Scholar]
  23. SuzukiK. OtaH. SasagawaS. SakataniT. FujikuraT. Assay method for myeloperoxidase in human polymorphonuclear leukocytes.Anal. Biochem.1983132234535210.1016/0003‑2697(83)90019‑2 6312841
     [Google Scholar]
  24. YoungL.M. KheifetsJ.B. BallaronS.J. YoungJ.M. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents.Agents Actions1989263-433534110.1007/BF01967298 2567568
     [Google Scholar]
  25. KrawiszJ.E. SharonP. StensonW.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity.Gastroenterology19848761344135010.1016/0016‑5085(84)90202‑6 6092199
     [Google Scholar]
  26. Haj-MirzaianA. AmiriS. Amini-KhoeiH. HosseiniM.J. Haj-MirzaianA. MomenyM. Rahimi-BalaeiM. DehpourA.R. Anxiety-and depressive-like behaviors are associated with altered hippocampal energy and inflammatory status in a mouse model of Crohn’s disease.Neuroscience201736612413710.1016/j.neuroscience.2017.10.023 29080717
     [Google Scholar]
  27. ImamF. Al-HarbiN.O. Al-HarbiM.M. AnsariM.A. AlmutairiM.M. AlshammariM. AlmukhlafiT.S. AnsariM.N. AljerianK. AhmadS.F. Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats.Toxicol. Mech. Methods201626970070810.1080/15376516.2016.1236425 27785949
     [Google Scholar]
  28. SingletonV.L. OrthoferR. Lamuela-RaventósR.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent.Methods Enzymol.199929929915217810.1016/S0076‑6879(99)99017‑1
     [Google Scholar]
  29. DuttaR. SharmaM.K. KhanA. JhaM. Phytochemical and in vitro antioxidant assay of Fumaria officinalis leaf extract.Int. J. Adv. Sci. Res.20201103176182
     [Google Scholar]
  30. Lamuela‐RaventósR.M. Chapter 6 - Folin–Ciocalteu method for the measurement of total phenolic content and antioxidant capacity. Measurement of Antioxidant Activity & Capacity: Recent Trends and Applications.Chapter 6Hoboken, New JerseyJohn Wiley & Sons Ltd.201819
     [Google Scholar]
  31. VillañoD. Fernández-PachónM.S. MoyáM.L. TroncosoA.M. García-ParrillaM.C. Radical scavenging ability of polyphenolic compounds towards DPPH free radical.Talanta200771123023510.1016/j.talanta.2006.03.050 19071293
     [Google Scholar]
  32. SałagaM. ZatorskiH. SobczakM. ChenC. FichnaJ. Chinese herbal medicines in the treatment of IBD and colorectal cancer: A review.Curr. Treat. Options Oncol.201415340542010.1007/s11864‑014‑0288‑2 24792017
     [Google Scholar]
  33. PengJ. ZhengT.T. LiX. LiangY. WangL.J. HuangY.C. XiaoH.T. Plant-derived alkaloids: the promising disease-modifying agents for inflammatory bowel disease.Front. Pharmacol.20191035110.3389/fphar.2019.00351 31031622
     [Google Scholar]
  34. MezhoudK. BenmokhtarM. SmatiD. Contribution to the study of Fumaria capreolata L. (Papaveraceae), in the Wilaya of Constantine: Phytochemical characterization and research of the anti-inflammatory activity.Bat. J. Med. Sci. (BJMS)201851262810.48087/BJMSoa.2018.5107
     [Google Scholar]
  35. SofianeI. SeridiR. Phytochemical profile, total phenolic content and antioxidant activity of ethanolic extract of fumitory (Fumaria capreolata L.) from Algeria.Eur. J. Biol. Res.2021114404416
     [Google Scholar]
  36. RaoC. VermaA. GuptaP. VijayakumarM. Anti-inflammatory and anti-nociceptive activities of Fumaria indica whole plant extract in experimental animals.Acta Pharm.200757449149810.2478/v10007‑007‑0039‑z 18165192
     [Google Scholar]
  37. KumarV. SinghG.K. RaiG. ChatterjeeS.S. Effects of ethanolic extract of Fumaria indica L. on rat cognitive dysfunctions.Ayu201334442142910.4103/0974‑8520.127727 24696581
     [Google Scholar]
  38. RizviW. FayazuddinM. SinghO. SyedS.N. MoinS. AkhtarK. KumarA. Anti-inflammatory effect of Fumaria parviflora leaves based on TNF-α, IL-1, IL-6 and antioxidant potential.Avicenna J. Phytomed.2017713745 28265545
     [Google Scholar]
  39. LiY. KongD. FuY. SussmanM.R. WuH. The effect of developmental and environmental factors on secondary metabolites in medicinal plants.Plant Physiol. Biochem.2020148808910.1016/j.plaphy.2020.01.006 31951944
     [Google Scholar]
  40. Prado, J.; Rostagno, M., Eds.; Natural product extraction: Principles and applicationsRoyal Society of ChemistryLondon202271730
     [Google Scholar]
  41. MensahM.L. KomlagaG. ForkuoA.D. FirempongC. AnningA.K. DicksonR.A. Toxicity and safety implications of herbal medicines used in Africa.Herb. Medic.20196351992199810.5772/intechopen.72437
     [Google Scholar]
  42. MorampudiV. BhinderG. WuX. DaiC. ShamH.P. VallanceB.A. JacobsonK. DNBS/TNBS colitis models: Providing insights into inflammatory bowel disease and effects of dietary fat.J. Vis. Exp.20142784e5129710.3791/51297 24637969
     [Google Scholar]
  43. WuL.H. XuZ.L. DongD. HeS-A. YuH. Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice.Evid. Based Complement. Alternat. Med.20112011152546210.1093/ecam/neq040
     [Google Scholar]
  44. NoubissiP.A. NjilifacQ. Fokam TagneM.A. Dongmo NguepiM.S. Foyet FondjoA. Kouémou EmégamN. Ngakou MukamJ. ZintchemR. WambeH. FankemG.O. Fotio TonfackA. ToukalaJ.P. Taiwe SotoingG. KamgamgR. Anxiolytic and anti-colitis effects of Moringa oleifera leaf-aqueous extract on acetic acid-induced colon inflammation in rat.Biomed. Pharmacother.202215411365210.1016/j.biopha.2022.113652 36067569
     [Google Scholar]
  45. AhnS.I. ChoS. ChoiN.J. Effect of dietary probiotics on colon length in an inflammatory bowel disease–induced murine model: A meta-analysis.J. Dairy Sci.202010321807181910.3168/jds.2019‑17356 31785874
     [Google Scholar]
  46. MorrisG.P. BeckP.L. HerridgeM.S. DepewW.T. SzewczukM.R. WallaceJ.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology198996379580310.1016/0016‑5085(89)90904‑9 2914642
     [Google Scholar]
  47. LugrinJ. Rosenblatt-VelinN. ParapanovR. LiaudetL. The role of oxidative stress during inflammatory processes.Biol. Chem.2014395220323010.1515/hsz‑2013‑0241 24127541
     [Google Scholar]
  48. BourgonjeA.R. FeelischM. FaberK.N. PaschA. DijkstraG. van GoorH. Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease.Trends Mol. Med.202026111034104610.1016/j.molmed.2020.06.006 32620502
     [Google Scholar]
  49. MouraF.A. de AndradeK.Q. dos SantosJ.C.F. AraújoO.R.P. GoulartM.O.F. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Redox Biol.2015661763910.1016/j.redox.2015.10.006 26520808
     [Google Scholar]
  50. van der VeenB.S. de WintherM.P.J. HeeringaP. Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease.Antioxid. Redox Signal.200911112899293710.1089/ars.2009.2538 19622015
     [Google Scholar]
  51. KlebanoffS.J. Myeloperoxidase: friend and foe.J. Leukoc. Biol.200577559862510.1189/jlb.1204697 15689384
     [Google Scholar]
  52. SwaminathanA. BorichevskyG.M. EdwardsT.S. HirschfeldE. MulesT.C. FramptonC.M.A. DayA.S. HamptonM.B. KettleA.J. GearryR.B. Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease.J. Crohn’s Colitis202216121862187310.1093/ecco‑jcc/jjac098 35803583
     [Google Scholar]
  53. Lazarević-PastiT. LeskovacA. VasićV. Myeloperoxidase inhibitors as potential drugs.Curr. Drug Metab.201516316819010.2174/138920021603150812120640 26279325
     [Google Scholar]
  54. TsumbuC.N. Deby-DupontG. TitsM. AngenotL. FrederichM. KohnenS. Mouithys-MickaladA. SerteynD. FranckT. Polyphenol content and modulatory activities of some tropical dietary plant extracts on the oxidant activities of neutrophils and myeloperoxidase.Int. J. Mol. Sci.201213162865010.3390/ijms13010628 22312276
     [Google Scholar]
  55. SoušekJ. GuédonD. AdamT. BochořákováH. TáborskáE. VálkaI. ŠimánekV. Alkaloids and organic acids content of eightFumaria species.Phytochem. Anal.199910161110.1002/(SICI)1099‑1565(199901/02)10:1<6::AID‑PCA431>3.0.CO;2‑0
     [Google Scholar]
  56. PăltineanR. MocanA. VlaseL. GheldiuA.M. CrișanG. IelciuI. VoștinaruO. CrișanO. Evaluation of polyphenolic content, antioxidant and diuretic activities of six Fumaria species.Molecules201722463910.3390/molecules22040639 28420145
     [Google Scholar]
  57. PereiraG.S. PercebomI. MendesS. SouzaP.S.S. DinizL.F.A. CostaM.F. LopesB.R.P. ToledoK.A. Quercetin inhibits neutrophil extracellular traps release and their cytotoxic effects on A549 cells, as well the release and enzymatic activity of elastase and myeloperoxidase.Braz. J. Biol.202484e25293610.1590/1519‑6984.252936 35475990
     [Google Scholar]
  58. SarkaratiB. Inhibitory effect of organic acids on human neutrophil myeloperoxidase’s peroxidation, chlorination, and nitration activities.Turk Biyokim. Derg.202348548549110.1515/tjb‑2022‑0260
     [Google Scholar]
  59. Alves de AlmeidaA.C. de-FariaF.M. DunderR.J. ManzoL.P.B. Souza-BritoA.R.M. Luiz-FerreiraA. Recent trends in pharmacological activity of alkaloids in animal colitis: Potential use for inflammatory bowel disease.Evid. Based Complement. Alternat. Med.201720171852821010.1155/2017/8528210 28191024
     [Google Scholar]
  60. AliI. KhanS.N. ChatzicharalampousC. BaiD. Abu-SoudH.M. Catalase prevents myeloperoxidase self-destruction in response to oxidative stress.J. Inorg. Biochem.201919711070610.1016/j.jinorgbio.2019.110706 31103890
     [Google Scholar]
  61. BeltránB. NosP. DasíF. IborraM. BastidaG. MartínezM. OʼConnorJ-E. SáezG. MoretI. PonceJ. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohnʼs disease.Inflamm. Bowel Dis.2010161768610.1002/ibd.21027 19637347
     [Google Scholar]
  62. El-AbharH.S. HammadL.N.A. GawadH.S.A. Modulating effect of ginger extract on rats with ulcerative colitis.J. Ethnopharmacol.2008118336737210.1016/j.jep.2008.04.026 18571884
     [Google Scholar]
  63. YeomY. KimY. The Sasa quelpaertensis leaf extract inhibits the dextran sulfate sodium-induced mouse colitis through modulation of antioxidant enzyme expression.J. Cancer Prev.201520213614610.15430/JCP.2015.20.2.136 26151047
     [Google Scholar]
  64. AlabiQ.K. AkomolafeR.O. OmoleJ.G. AdefisayoM.A. OgundipeO.L. AturamuA. SanyaJ.O. Polyphenol-rich extract of Ocimum gratissimum leaves ameliorates colitis via attenuating colonic mucosa injury and regulating pro-inflammatory cytokines production and oxidative stress.Biomed. Pharmacother.201810381282210.1016/j.biopha.2018.04.071 29684860
     [Google Scholar]
  65. BarrettK.E. McColeD.F. Hydrogen peroxide scavenger, catalase, alleviates ion transport dysfunction in murine colitis.Clin. Exp. Pharmacol. Physiol.201643111097110610.1111/1440‑1681.12646 27543846
     [Google Scholar]
  66. AtanasovA.G. WaltenbergerB. Pferschy-WenzigE.M. LinderT. WawroschC. UhrinP. TemmlV. WangL. SchwaigerS. HeissE.H. RollingerJ.M. SchusterD. BreussJ.M. BochkovV. MihovilovicM.D. KoppB. BauerR. DirschV.M. StuppnerH. Discovery and resupply of pharmacologically active plant-derived natural products: A review.Biotechnol. Adv.20153381582161410.1016/j.biotechadv.2015.08.001 26281720
     [Google Scholar]
  67. KiumarsiF. DerakhshanA.R. Gastrointestinal and hepatic effects of fumaria species in traditional persian medicine and modern medical studies: a narrative review.J. Sabze. Univer. Med. Sci.2022295697718
     [Google Scholar]
/content/journals/cbc/10.2174/0115734072378267250514104332
Loading
Antioxidant and Intestinal Anti-inflammatory Activities of the Ethanolic Extract of Fumaria capreolata in Experimental Animals of Colitis
Curr. Bioact. Compd. 22, E15734072378267 (2026); https://doi.org/10.2174/0115734072378267250514104332
/content/journals/cbc/10.2174/0115734072378267250514104332
/content/journals/cbc/10.2174/0115734072378267250514104332
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): colitis; Crohn's disease; Fumaria capreolata; inflammatory bowel disease; polyphenols; ulcerative colitis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test